{
    "nct_id": "NCT00359944",
    "title": "A Phase II, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Assessing the Efficacy and Safety of AC-3933 Tablets Twice Daily in Adults With Mild to Moderate Alzheimer's Disease",
    "status": "COMPLETED",
    "last_update_time": "2013-05-28",
    "description_brief": "The purpose of this study is to investigate efficacy and safety of different doses of AC-3933 in patients with mild to moderate Alzheimer's Disease.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "preAssignmentDetails": "17 patients were excluded from analysis because of QA issues at a study site.",
            "groups": [
                {
                    "id": "FG000",
                    "title": "AC-3933, 5 mg",
                    "description": "AC-3933, 5mg twice daily"
                },
                {
                    "id": "FG001",
                    "title": "AC-3933, 20 mg",
                    "description": "AC-3933, 20 mg twice daily"
                },
                {
                    "id": "FG002",
                    "title": "Placebo",
                    "description": "Sugar Pill twice daily"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "50"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "47"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "57"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "34"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "28"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "38"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "16"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "19"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "19"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "populationDescription": "132 subjects were from the full analysis set, which was defined as all randomized subjects who took at least one dose of study drug and had greater than/equal to one post-baseline ADAS-Cog assessment",
            "groups": [
                {
                    "id": "BG000",
                    "title": "AC-3933",
                    "description": "AC-3933, 5mg twice daily"
                },
                {
                    "id": "BG001",
                    "title": "AC-3933, 20 mg",
                    "description": "AC-3933, 20 mg twice daily"
                },
                {
                    "id": "BG002",
                    "title": "Placebo",
                    "description": "Sugar Pill twice daily"
                },
                {
                    "id": "BG003",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "43"
                        },
                        {
                            "groupId": "BG001",
                            "value": "40"
                        },
                        {
                            "groupId": "BG002",
                            "value": "49"
                        },
                        {
                            "groupId": "BG003",
                            "value": "132"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Categorical",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "<=18 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Between 18 and 65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": ">=65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "43"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "40"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "49"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "132"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Age Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "75.5",
                                            "spread": "8.57"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "74.8",
                                            "spread": "9.54"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "76.3",
                                            "spread": "8.73"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "75.6",
                                            "spread": "8.88"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "30"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "27"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "95"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "11"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "37"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "43"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "40"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "49"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "132"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Total Score of Alzheimer's Disease Assessment Scale - Cognition Subscale (ADAS-COG)From Best Total Score (0) to Worst Total Score (70)",
                    "description": "Change from baseline to week 16 of the double blind treatment in the Alzheimer's Disease Assessment Scale - Cognition Subscale (ADAS-COG) total score The Alzheimer's Disease Assessment Scale if used for assessing the severity of dysfuncion and for research in patients with AD, particularly in clinical drug trials. It consists of 11 items testing orientatin, memory, word usage and recognition, receptive speech, spatial abilities, ideational praxis, ability to follow instructions, spontanious speech abilities, and comprehension. The higher the overall score (maximum 70), the more severe the dysfunction/impairment.",
                    "reportingStatus": "POSTED",
                    "anticipatedPostingDate": "2010-04",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to 16 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "AC-3933, 5 mg",
                            "description": "AC-3933, 5mg twice daily"
                        },
                        {
                            "id": "OG001",
                            "title": "AC-3933, 20 mg",
                            "description": "AC-3933, 20 mg twice daily"
                        },
                        {
                            "id": "OG002",
                            "title": "Placebo",
                            "description": "Sugar Pill twice daily"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "43"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "40"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "49"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.3",
                                            "spread": "0.84"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-2.9",
                                            "spread": "0.88"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-1.5",
                                            "spread": "0.78"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Clinicians Interview Based Impression of Change (CIBIC)-Plus",
                    "description": "Clinicians Interview Based Impression of Change (CIBIC)-Plus-Plus scores at week 16 of the double blind treatment.\n\nCIBIC-Plus is ranged between 1 and 7 (1=very much improved, 4=no change, and 7=very much worsened). We were expecting smaller value of CIBIC-Plus at the study end.",
                    "reportingStatus": "POSTED",
                    "anticipatedPostingDate": "2010-04",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to 16 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "AC-3933, 5 mg",
                            "description": "AC-3933, 5mg twice daily"
                        },
                        {
                            "id": "OG001",
                            "title": "AC-3933, 20 mg",
                            "description": "AC-3933, 20 mg twice daily"
                        },
                        {
                            "id": "OG002",
                            "title": "Placebo",
                            "description": "Sugar Pill twice daily"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "43"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "40"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "49"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4.1",
                                            "spread": "0.97"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3.9",
                                            "spread": "1.11"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "3.9",
                                            "spread": "0.91"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Disability Assessment for Dementia (DAD)",
                    "description": "Change from baseline to week 16 of the double blind treatment in the Disability Assessment for Dementia (DAD) scores.\n\nThe DAD is administered as a clinician-assisted interview with the caregiver and was developed to assess functional abilities in ADLs in community-dwelling dementia patients. The scale consists of 40 questions assessing basic and instumental ADLs. A total score is obtained by adding the rating for each question and converting this total score out of 100. The items rated N/A are not considered for the total score. Higher scores represent less disability in activities of daily living (ADL) while lower scores indicate more dysfunction.",
                    "reportingStatus": "POSTED",
                    "anticipatedPostingDate": "2010-04",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline to 16 Weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "AC-3933, 5 mg",
                            "description": "AC-3933, 5mg twice daily"
                        },
                        {
                            "id": "OG001",
                            "title": "AC-3933, 20 mg",
                            "description": "AC-3933, 20 mg twice daily"
                        },
                        {
                            "id": "OG002",
                            "title": "Placebo",
                            "description": "Sugar Pill twice daily"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "43"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "40"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "49"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.7",
                                            "spread": "1.89"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "4.0",
                                            "spread": "2.10"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "4.2",
                                            "spread": "1.80"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "February 2006 to September 2008",
            "description": "The AE summary was based on the safety population, which was defined as all randomized patients who received at least one dose of the study drug (58 placebo, 50 AC-3933 5mg, 46 AC-3933 20mg. Once subject randomized to AC-3933 20mg group received placebo during the course of the study. So this subject was summarized in the placebe group.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "AC-3933, 5 mg",
                    "description": "AC-3933, 5mg twice daily",
                    "seriousNumAffected": 5,
                    "seriousNumAtRisk": 50,
                    "otherNumAffected": 11,
                    "otherNumAtRisk": 50
                },
                {
                    "id": "EG001",
                    "title": "AC-3933, 20 mg",
                    "description": "AC-3933, 20 mg twice daily",
                    "seriousNumAffected": 4,
                    "seriousNumAtRisk": 46,
                    "otherNumAffected": 12,
                    "otherNumAtRisk": 46
                },
                {
                    "id": "EG002",
                    "title": "Placebo",
                    "description": "Sugar Pill twice daily",
                    "seriousNumAffected": 5,
                    "seriousNumAtRisk": 58,
                    "otherNumAffected": 17,
                    "otherNumAtRisk": 58
                }
            ],
            "seriousEvents": [
                {
                    "term": "Cardiac Failure congestive",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Cardiomyopathy",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Tachycardia",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Abdominal Mass",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Fatigue",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Bronchitis acute",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Eye Injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Rib Fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Blood Pressure Increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Anorexia",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Colon Cancer stage IV",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Metastases to liver",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Prostate cancer",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Syncope",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Abnormal Behavior",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Benign prostatic hyperplasia",
                    "organSystem": "Reproductive system and breast disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Dyspnoea",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Hyperhidrosis",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 58
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Anxiety",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 4,
                            "numAffected": 4,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 4,
                            "numAffected": 4,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Dizziness",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Urinary Tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Electroencephalogram abnormal",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 4,
                            "numAffected": 4,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Nausea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 6,
                            "numAffected": 6,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 58
                        }
                    ]
                },
                {
                    "term": "Vomiting",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (9.0)",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 50
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 46
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 58
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Medical Director, CNS",
                "organization": "Sunovion",
                "phone": "1-866-503-6351"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "AC-3933 \u2014 small\u2011molecule benzodiazepine\u2011receptor (BzR) partial inverse agonist (procognitive; increases hippocampal acetylcholine release)"
    ],
    "placebo": [
        "Sugar pill (placebo)"
    ],
    "explanation_target": [
        "Reason: The compound AC-3933 is described in the pharmacology literature as a benzodiazepine\u2011receptor (BzR) partial inverse agonist that enhances acetylcholine release and improves memory in preclinical models \u2014 i.e., a procognitive mechanism rather than an anti\u2011amyloid or anti\u2011tau disease\u2011modifying approach. \ue200cite\ue202turn1search3\ue202turn1search6\ue201",
        "Act: The clinical trial (NCT00359944) is a Phase II, randomized, placebo\u2011controlled, dose\u2011ranging study of AC\u20113933 tablets in mild\u2013moderate AD (arms included AC\u20113933 5 mg bid, AC\u20113933 20 mg bid, and placebo; primary outcome ADAS\u2011Cog), confirming the drug was tested as a cognition\u2011improvement treatment in patients. \ue200cite\ue202turn1search2\ue201",
        "Reflect: Given the intervention is a small molecule acting at the benzodiazepine site to enhance cholinergic function and improve cognition (not a biologic targeting amyloid/tau, nor an agent aimed primarily at neuropsychiatric symptoms), the appropriate category is 'cognitive enhancer'. Development was later discontinued after Phase II results did not meet company criteria, which explains limited subsequent development. \ue200cite\ue202turn1search4\ue201",
        "Web search results used (key sources): PubMed pharmacology/pharmacodynamics of AC\u20113933 (mechanism, procognitive data). \ue200cite\ue202turn1search3\ue202turn1search6\ue201; Clinical trial registry / Phase II trial NCT00359944 (trial design, doses, ADAS\u2011Cog primary outcome). \ue200cite\ue202turn1search2\ue201; Sumitomo/Dainippon press release noting discontinuation after Phase II. \ue200cite\ue202turn1search4\ue201"
    ],
    "agent_type": "D) Neurotransmitter Receptors",
    "explanation_agent": [
        "Reason: AC-3933 is a benzodiazepine\u2011receptor (BzR) partial inverse agonist that modulates the GABA(A) benzodiazepine site and increases hippocampal acetylcholine release \u2014 i.e., it acts via neurotransmitter\u2011receptor modulation to produce a procognitive effect rather than targeting amyloid, tau, inflammation, or other disease\u2011modifying pathways. \ue200cite\ue202turn0search0\ue202turn0search1\ue201",
        "Act: The listed Phase II study tested AC\u20113933 as a cognitive enhancer in mild\u2013moderate AD with ADAS\u2011Cog as the primary outcome (NCT00359944; dose arms 5 mg bid and 20 mg bid vs placebo), confirming a symptomatic, neurotransmitter\u2011receptor based strategy rather than an anti\u2011amyloid/tau approach. \ue200cite\ue202turn1search2\ue202turn1search0\ue201",
        "Reflect: Classification as 'D) Neurotransmitter Receptors' aligns with CADRO because the drug\u2019s mechanism is modulation of the benzodiazepine/GABA(A) receptor complex (a neurotransmitter receptor) to enhance cholinergic transmission and cognition. Development was discontinued after Phase II did not meet company criteria (supports historical trial outcome but does not change mechanism). \ue200cite\ue202turn0search2\ue201",
        "Sources (key web search results used):",
        "- PubMed: Pharmacological properties of AC\u20113933, a novel benzodiazepine receptor partial inverse agonist (describes binding, increased hippocampal ACh release and procognitive rationale). \ue200cite\ue202turn0search0\ue201",
        "- PubMed: In vivo pharmacological characterization of AC\u20113933 (procognitive effects in animal models). \ue200cite\ue202turn0search1\ue201",
        "- PubMed: Procognitive effect of AC\u20113933 in aged mice and synergy with donepezil. \ue200cite\ue202turn0search3\ue201",
        "- Company press release (Sumitomo/Dainippon) announcing discontinuation after Phase II results. \ue200cite\ue202turn0search2\ue201",
        "- Clinical trial registry / study record for NCT00359944 (trial design, doses, ADAS\u2011Cog primary outcome). \ue200cite\ue202turn1search2\ue202turn1search0\ue201"
    ]
}